Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-10

Clinical Trial Update: Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan. [Phase 3]

View source ↗

Summary

A Phase 3 trial in Japan evaluating zinc acetate for Wilson's disease has completed enrollment and the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc acetate (zinc acetate)

Snippet

Sponsor: Nobelpharma | Conditions: Wison's Disease | Phase 3 | Status: COMPLETED